대한내분비학회 소식지

대한내분비학회 홈페이지

간행위원회

  이번 EnM 31권 3호에는 7 편의 종설, 그리고 10편의 원저, 1편의 brief report가 실렸습니다. 인제 의대 노정현 교수님께서 “The Diabetes Epidemic in Korea”  라는 제목으로 국민건강영양조사 자료 및 국민건강보험공단자료를 바탕으로 우리나라에 당뇨병 관련 역학에 대해서 알려주셨습니다. 강북삼성병원 이원영 교수님께서는 “Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients”  라는 제목으로 지난 30년간 우리나라에서 당뇨병이 증가하는데 인슐린저항성 증가가 기여하며, 인슐린 분비능과 인슐린 저항성과 관련된 국내 여러 연구결과를 정리해서 발표해 주셨습니다. 하버드 대학의 Mantzoros교수님께서 “Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss” 제목으로 energy homeostasis에 관여하는 novel molecules (FGF-21, chemerin, irisin등)에 대해서 리뷰해 주셨습니다.

  이번 호에는 특히 갑상선 관련 종설 4편이 실렸으며, 갑상선 결절 및 갑상선암 진료가이드라인, 자가면역성 갑상선 질환 치료, 임신 시에 갑상선 질환 치료, 갑상선 수질암 치료와 관련된 최신 지견이 실려있습니다.

  연구논문으로 강북삼성병원 이은정 교수님께서 “Eligibility for Statin Treatment in Koeran Subjects with Reduced renal function: An observational study”  라는 제목으로 신장기능이 떨어진 사람에서 여러 콜레스테롤 치료 가이드라인에 따른 Statin eligibility에 대한 연구 결과를 발표하였습니다. 아산병원 전민지 선생님께서 “Comparison of Thyroglobulin Measurements using Three different Immnunoassay Kits” 라는 제목으로 최근 사용이 가능한 Second generation Tg immuometric assays법의 유용성에 대해서 시행한 연구결과를 발표하였습니다. 이 밖에도 다양한 내분비 영역에서 연구 논문들이 원저로서 이번 호에 실렸습니다. 회원 여러분의 많은 관심 부탁드립니다.

(31권 3호 바로 보기 )

EnM

EnM을 SCI(E)급 저널에 인용해주신 분들을 소개해
드립니다.

  • 1.가톨릭의대 이승환
    - Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, Lyoo IK. Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab (Seoul). 2014 Jun;29(2):112-21.
    To
    Lee SH, Zabolotny JM, Huang H, Lee H, Kim YB. Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood. Mol Metab. 2016 Jun 29;5(8):589-601.
  • 2.울산의대 전민지
    - Hong AR, Lim JA, Kim TH, Choi HS, Yoo WS, Min HS, Won JK, Lee KE, Jung KC, Park do J, Park YJ. The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades. Endocrinol Metab (Seoul). 2014 Dec 29;29(4):505-13.
    To
    Jeon MJ, Chun SM, Kim D, Kwon H, Jang EK, Kim TY, Kim WB, Shong YK, Jang SJ, Song DE, Kim WG. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area. Thyroid. 2016 May;26(5):683-90.
    - Kim TY, Kim WG, Kim WB, Shong YK. Current status and future perspectives in differentiated thyroid cancer. Endocrinol Metab (Seoul). 2014 Sep;29(3):217-25.
    - Kwak JY. Indications for fine needle aspiration in thyroid nodules. Endocrinol Metab (Seoul). 2013 Jun;28(2):81-5.
    To
    Jeon MJ, Kim WG, Choi YM, Kwon H, Lee YM, Sung TY, Yoon JH, Chung KW, Hong SJ, Kim TY, Shong YK, Song DE, Kim WB. Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas. Thyroid. 2016 Jan;26(1):161-8.
  • 3.가톨릭의대 양혜경
    - Lee SH, Ha HS, Park YJ, Lee JH, Yim HW, Yoon KH, Kang MI, Lee WC, Son HY, Park YM, Kwon HS. Prevalence and Characteristics of Metabolically Obese but Normal Weight and Metabolically Healthy but Obese in Middle-aged Koreans: the Chungju Metabolic Disease Cohort (CMC) Study. Endocrinol Metab. 2011 Jun;26(2):133-141.
    - Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab (Seoul). 2014 Dec 29;29(4):427-34.
    To
    Yang HK, Han K, Kwon HS, Park YM, Cho JH, Yoon KH, Kang MI, Cha BY, Lee SH. Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea. Sci Rep. 2016 Jul 22;6:30329.
  • 4.서울의대 문재훈
    - Holick MF. Vitamin D: A D-Lightful Vitamin for Health. Endocrinol Metab (Seoul). 2012 Dec;27(4):255-267.
    To
    Moon JH, Jung KY, Kim KM, Choi SH, Lim S, Park YJ, Park do J, Jang HC. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma. Bone. 2016 Feb;83:104-10.
  • 5.연세의대 한유진
    - Kim MJ, Han JY, Shin JY, Kim SI, Lee JM, Hong S, et al. Metformin-associated lactic acidosis: predisposing factors and outcome. Endcorinol Metab (Seoul) 2015;30(1):78–83.
    - Cho YM, Wideman RD, Kieffer TJ. Clinical application of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetesmellitus. Endocrinol Metab (Seoul) 2013;28:262–74.
    - Bae J, Lee MJ, Choe EY, Jung CH, Wang HJ, Kim MS, et al. Effects of Dipeptidyl peptidase-4 inhibitors on hyperglycemia and blood cyclosporine levels in renal transplant patients with diabetes: a pilot study. Endocrinol Metab (Seoul) 2016;31(1):161–7.
    To
    Han E, Kang ES. Risk assessment and management of post-transplant diabetes mellitus. Metabolism. 2016:1559-69.
  • 6.성균관의대 김태혁
    - Song YS, Lim JA, Park YJ. Mutation Profile of Well-Differentiated Thyroid Cancer in Asians. Endocrinol Metab (Seoul). 2015 Sep;30(3):252-62.
    To
    Han E, Kang ES. Risk assessment and management of post-transplant diabetes mellitus. Metabolism. 2016:1559-69.
  • 7.고려의대 김남훈
    - Ha KH, Kim DJ. Trends in the Diabetes Epidemic in Korea. Endocrinol Metab (Seoul). 2015 Jun;30(2):142-6.
    To
    Kim NH, Kim TJ, Kim NH, Choi KM, Baik SH, Choi DS, Park Y, Kim SG. Relative and combined effects of socioeconomic status and diabetes on mortality: A nationwide cohort study. Medicine (Baltimore). 2016 Jul;95(30):e4403.
  • 8.가톨릭의대 김헌성
    - Ha KH, Kim DJ. Trends in the Diabetes Epidemic in Korea. Endocrinol Metab (Seoul). 2015 Jun;30(2):142-6.
    - Kim HS, Cho JH, Yoon KH. New Directions in Chronic Disease Management. Endocrinol Metab (Seoul). 2015 Jun;30(2):159-66.
    - Lee DH, Jung KY, Park KS, Kim KM, Moon JH, Lim S, Jang HC, Choi SH. Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011. Endocrinol Metab (Seoul). 2015 Dec;30(4):514-21.
    - Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, Kim EM, Suh SH, Shin HJ, Lee KR, Lee KY, Lee SY, Lee SY, Lee SK, Lee CB, Chung S, Jeong IK, Hur KY, Kim SS, Woo JT, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity. 2014 Clinical Practice Guidelines for Overweight and Obesity in Korea. Endocrinol Metab (Seoul). 2014 Dec;29(4):405-409
    To
    Kim HS, Jeong YJ, Baik SJ, Yang SJ, Kim TM, Kim H, Lee H, Lee SH, Cho JH, Choi IY, Yoon KH. Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea. Appl Clin Inform. 2016 Sep 28;7(3):899-911.
  • 9.서울의대 박영주
    - Hong AR, Lim JA, Kim TH, et al. The frequency and clinical implications of the BRAF(V600E) mutation in papillary thyroid cancer patients in Korea over the past two decades. Endocrinol Metab (Seoul). 2014;29:505-513.
    - Song YS, Lim JA, Park YJ. Mutation profile of well-differentiated thyroid cancer in Asians. Endocrinol Metab (Seoul). 2015;30:252-262.
    To
    Song YS, Lim JA, Choi H, Won JK, Moon JH, Cho SW, Lee KE, Park YJ, Yi KH, Park do J, Seo JS. Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients. Cancer. 2016 May 1;122(9):1370-9.
  • 10.가톨릭의대 김미경
    - Lee J, Lee S, Jang S, Ryu OH. Age-Related Changes in the Prevalence of Osteoporosis according to Gender and Skeletal Site: The Korea National Health and Nutrition Examination Survey 2008-2010. Endocrinol Metab (Seoul). 2013 Sep;28(3):180-91.
    To
    Kim MK, Kwon HS, Song KH, Kang MI, Baek KH. The Relationship of Serum Serotonin Levels to the Rate of Bone Loss and Fractures in Men. J Clin Densitom. 2016 Sep 7. pii: S1094-6950(16)30113-5.

EnM을 인용해주신 분들께 진심으로 감사드리며, 앞으로도 EnM에 대한 많은 관심과 인용을 부탁드립니다.

서울특별시 마포구 만리재로 14 한국사회복지회관 르네상스타워 빌딩 9층 901호 (우) 04195    Tel : 02-714-2428 / 716-2428
Fax : 02-714-5103     E-mail : endo@endocrinology.or.kr     사업자등록번호 : 106-82-31113     대표자 : 송영기

Copyright(c) Korean Endocrine Society. All rights reserved.